Pamela Stephenson's most recent trade in Disc Medicine Inc was a trade of 3,137 Common Stock done at an average price of $54.6 . Disclosure was reported to the exchange on Feb. 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Disc Medicine Inc | Pamela Stephenson | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 54.58 per share. | 18 Feb 2025 | 3,137 | 69,529 | - | 54.6 | 171,217 | Common Stock |
| Disc Medicine Inc | Pamela Stephenson | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | Pamela Stephenson | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 36,000 | 72,666 | - | 0 | Common Stock | |
| Disc Medicine Inc | Pamela Stephenson | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | Pamela Stephenson | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 36,666 | 36,666 | - | 0 | Common Stock | |
| Zynerba Pharmaceuticals Inc | Pamela Stephenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 71,736 | 71,736 | - | - | Stock Option (right to buy) | |
| Zynerba Pharmaceuticals Inc | Pamela Stephenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 47,824 | 75,893 (0%) | 0% | 0 | Common Stock | |
| Zynerba Pharmaceuticals Inc | Pamela Stephenson | Director | Sale of securities on an exchange or to another person at price $ 0.35 per share. | 13 Jun 2023 | 115 | 75,778 (0%) | 0% | 0.3 | 40 | Common Stock |
| Zynerba Pharmaceuticals Inc | Pamela Stephenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 34,663 | 34,663 | - | - | Stock Option (right to buy) | |
| Zynerba Pharmaceuticals Inc | Pamela Stephenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 23,109 | 28,109 (0%) | 0% | 0 | Common Stock | |
| Zynerba Pharmaceuticals Inc | Pamela Stephenson | Director | Sale of securities on an exchange or to another person at price $ 1.00 per share. | 14 Jun 2022 | 40 | 28,069 (0%) | 0% | 1 | 40 | Common Stock |
| Zynerba Pharmaceuticals Inc | Pamela Stephenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
| Zynerba Pharmaceuticals Inc | Pamela Stephenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 5,000 | 5,000 (0%) | 0% | 0 | Common Stock |